James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Ralph Lauren, Fastenal Company and Wynn Resorts Are 3 of Today’s Worst Stocks

Ralph Lauren Corp., Fastenal Company and Wynn Resorts, Limited just couldn't win for losing on Wednesday. Here's why.

GILD Stock Tanks After Earnings: Opportunity, or Omen?

GILD stock is taking on water following the less-than-thrilling Gilead earnings report and guidance, but a closer look is merited.

Why Stratasys, ISIS Pharmaceuticals and Heartland Express Are 3 of Today’s Worst Stocks

ISIS Pharmaceuticals, Stratasys and Heartland Express found themselves at the bottom of the barrel on Tuesday, but for understandable reasons.

5 Stocks That Are WAY Ahead of the Curve

The term "game-changing" is overused, and even abused, within the investment community. For these stocks, though, it's perfectly accurate.

Dow Chemical Is Quietly Building Steam (DOW)

Dow Chemical Co shares have been beaten down since September, but some are starting to correct their mistake. Here's our read on DOW stock.